Levine Zurit 4

What Happened

• Levine Zurit, SVP Business Development at Compugen Ltd (CGEN), exercised stock options and completed a sale on April 14, 2026. The filing shows: 2,000 shares acquired by exercise at $1.15 per share (cost $2,300), and 2,000 shares sold in an open-market transaction at $2.80 per share for proceeds of $5,600. The report also lists a derivative disposal of 2,000 shares at $0.00 (the filing does not explain the mechanism for that entry).

Key Details

• Transaction date: 2026-04-14 (filed 2026-04-15)
• Exercise: 2,000 shares @ $1.15 = $2,300 (code M)
• Open-market sale: 2,000 shares @ $2.80 = $5,600 (code S)
• Derivative disposition: 2,000 shares @ $0.00 (code M) — no further detail in the filing
• Shares owned after transaction: Not specified in this Form 4
• Footnotes: F1 — sale made pursuant to a Rule 10b5-1 trading plan adopted Dec 23, 2025. F2 — the option vesting schedule (25% vested 9/30/2024; remainder vests quarterly)
• Filing timeliness: Report was filed the next day; not indicated as late

Context

• This appears to be an option exercise with at least some proceeds realized via an open-market sale. The 10b5-1 note indicates the sale was made under a pre-established plan, which is commonly used to automate insider sales and avoid timing questions. The $0.00 derivative line is shown in the filing but not explained (could reflect net settlement or other administrative treatment); the Form 4 does not provide further detail.